Neonatal hyperviscosity. II. Effect of partial plasma exchange transfusion

Area of Science:

• Neonatal Medicine
• Hematology

Background:

• Neonatal hyperviscosity syndrome is a condition characterized by increased blood viscosity in newborns.
• Elevated blood viscosity can lead to organ damage and neurological complications.

Purpose of the Study:

• To evaluate the efficacy of partial plasma exchange transfusion in treating neonatal hyperviscosity.
• To assess the impact of this treatment on organ involvement, neurological behavior, and long-term development.

Main Methods:

• Randomized controlled trial involving 20 newborn infants with neonatal hyperviscosity.
• Infants were assigned to either observation or partial plasma exchange transfusion within 8 hours of birth.
• Comprehensive assessments included organ imaging, blood counts, coagulation studies, and neurological assessments using the Brazelton Neonatal Behavior Assessment scale.

Main Results:

• Partial plasma exchange transfusion effectively reduced blood viscosity.
• Both hyperviscous groups (treated and untreated) showed more abnormal results than controls.
• Infants receiving exchange transfusions showed faster initial neurological improvement, becoming indistinguishable from controls by 2-3 weeks.
• Neurological improvement was significantly slower in untreated hyperviscous infants.
• At 8 months, both hyperviscous groups exhibited significant neurological and developmental abnormalities, with no significant differences between treated and untreated infants.

Conclusions:

• While partial plasma exchange transfusion improves neonatal hyperviscosity and initial neurological symptoms, it does not prevent long-term neurological and developmental deficits.
• Both treated and untreated hyperviscous infants showed significant abnormalities at 8 months, suggesting the need for further research into optimal management strategies.